DOTS chemotheraphy is given for –
**Core Concept**
DOTS (Directly Observed Treatment, Short-course) chemotherapy is a tuberculosis (TB) treatment strategy that involves the administration of antitubercular medications under direct supervision to ensure adherence and prevent the development of drug-resistant TB. This approach is crucial in managing TB, particularly in areas with high prevalence and limited resources.
**Why the Correct Answer is Right**
The correct answer is for **Pulmonary Tuberculosis (TB)**. DOTS chemotherapy is specifically designed to treat active TB, particularly pulmonary TB, which accounts for the majority of TB cases. The regimen typically consists of a combination of first-line antitubercular drugs, including isoniazid, rifampicin, pyrazinamide, and ethambutol, administered for a period of 6 months. This ensures the effective killing of Mycobacterium tuberculosis, the causative agent of TB, and prevents the development of drug resistance.
**Why Each Wrong Option is Incorrect**
**Option A:** DOTS chemotherapy is not typically used for **Extrapulmonary TB**, which refers to TB affecting organs or tissues outside the lungs. While DOTS can be adapted for extrapulmonary TB, the approach may differ from that used for pulmonary TB.
**Option B:** DOTS chemotherapy is not primarily used for **HIV-associated TB**. While HIV infection increases the risk of developing TB, the treatment approach for HIV-associated TB may involve additional considerations, such as antiretroviral therapy and more intensive TB treatment regimens.
**Option C:** DOTS chemotherapy is not specifically designed for **Latent TB infection**. Latent TB infection (LTBI) refers to a state where an individual is infected with M. tuberculosis but does not exhibit active TB symptoms. Treatment for LTBI typically involves a shorter course of isoniazid or rifampicin.
**Clinical Pearl / High-Yield Fact**
Remember that DOTS chemotherapy is a critical component of TB control programs worldwide, particularly in areas with high TB prevalence. Adherence to the DOTS regimen is essential to prevent the development of drug-resistant TB and ensure effective TB treatment outcomes.
**Correct Answer:** C.